Johnson & Johnson (JNJ) Profit Margin (2012 - 2026)
Johnson & Johnson (JNJ) profit margin from Jul 1, 2012 to Mar 29, 2026. The current Johnson & Johnson (JNJ) profit margin is 21.76%. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Profit Margin
Quarterly Profit Margin
Annual Profit Margin change of Johnson & Johnson (JNJ)
| Year | Profit Margin | Change |
|---|---|---|
| 2025 | 28.46% | +79.69% |
| 2024 | 15.84% | -61.64% |
| 2023 | 41.28% | +84.04% |
| 2023 | 22.43% | +0.60% |
| 2022 | 22.29% | -6.38% |
| 2022 | 23.81% | -8.24% |
| 2022 | 25.95% | -2.12% |
| 2022 | 26.52% | +48.82% |
| 2021 | 17.82% | -3.30% |
| 2019 | 18.42% | -1.74% |
| 2018 | 18.75% | -3.01% |
| 2018 | 19.33% | +1.85% |
| 2018 | 18.98% | -13.03% |
| 2018 | 21.83% | +1183.49% |
| 2017 | 1.70% | -91.12% |
| 2017 | 19.16% | -5.71% |
| 2017 | 20.31% | -18.38% |
| 2017 | 24.89% | +8.18% |
| 2017 | 23.01% | N/A |
Comparison Johnson & Johnson (JNJ) profit margin with competitors
Johnson & Johnson (JNJ) profit margin is 21.76%.
| Ticker | Name | Profit Margin | Upside |
|---|---|---|---|
| NVO | Novo Nordisk | 50.15% | +130.51% |
| LLY | Lilly(Eli) & Company | 37.36% | +71.72% |
| GILD | Gilead Sciences Inc | 29.04% | +33.48% |
| NVS | Novartis AG | 23.34% | +7.28% |
| BMY | Bristol-Myers Squibb Company | 23.30% | +7.10% |
| GSK | GSK Plc | 22.77% | +4.66% |
| AMGN | AMGEN Inc | 21.11% | -2.97% |
| AZN | Astrazeneca plc | 20.15% | -7.38% |
| PFE | Pfizer Inc | 18.59% | -14.55% |
| SNY | Sanofi | 14.35% | -34.04% |
| BIIB | Biogen Inc | 12.89% | -40.75% |
| OGN | Organon & Company | 10.00% | -54.04% |
| ABBV | Abbvie Inc | 4.63% | -78.72% |
| GRFS | Grifols SA | 4.29% | -80.28% |